Table: OncoTherapy Science - 6-MTH group results

OncoTherapy Science

06/11/2020 08:00

Nov 6 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2020        Sep 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            100 mln             104 mln                    
                 (-3.5 pct)         (+327.5 pct)                  
  Operating     loss 838 mln          loss 1.22                   
  Recurring     loss 835 mln          loss 1.22                   
  Net           loss 756 mln          loss 1.26                   
  EPS           loss 4.29 yen       loss 8.01 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T